The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis

INTRODUCTION: Rotavirus vaccines were introduced into the Australian National Immunisation Program in 2007. Despite this, Northern Territory Indigenous children continue to be hospitalised with rotavirus at a rate more than 20 times higher than non-Indigenous children in other Australian jurisdictio...

Descripción completa

Detalles Bibliográficos
Autores principales: Middleton, Bianca Fleur, Jones, Mark A, Waddington, Claire S, Danchin, Margaret, McCallum, Carly, Gallagher, Sarah, Leach, Amanda Jane, Andrews, Ross, Kirkwood, Carl, Cunliffe, Nigel, Carapetis, Jonathan, Marsh, Julie A, Snelling, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886966/
https://www.ncbi.nlm.nih.gov/pubmed/31727664
http://dx.doi.org/10.1136/bmjopen-2019-032549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886966/
https://www.ncbi.nlm.nih.gov/pubmed/31727664
http://dx.doi.org/10.1136/bmjopen-2019-032549

Ejemplares similares